Voyager Therapeutics to Participate in Upcoming Investor Conferences
Voyager Therapeutics (Nasdaq: VYGR) announced its participation in two upcoming investor conferences. The first is Chardan’s 6th Annual Genetic Medicines Conference on October 4, 2022, featuring a company presentation at 3:45 p.m. ET. The second event is the Truist Securities Genetic Medicine Summit on October 20, 2022, where Voyager will participate in a CNS panel discussion (not webcast). Interested investors can access the presentation and archived webcasts on Voyager's website for 30 days following the events.
- None.
- None.
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today announced that management will participate in the following investor conferences:
- Chardan’s 6th Annual Genetic Medicines Conference, New York, NY – Company presentation, October 4, 2022, 3:45 p.m. ET
- Truist Securities Genetic Medicine Summit, New York, NY – CNS panel discussion (not webcast), October 20, 2022
The presentation may be accessed from the Investors section of Voyager’s website at www.voyagertherapeutics.com. Replays of webcasts are archived on the Company's website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the modality to treat devastating diseases. Proprietary capsids born from Voyager’s TRACER capsid discovery platform are powering a rich early-stage pipeline of programs and may elevate the field to overcome the narrow therapeutic window associated with conventional gene therapy vectors across neurologic disorders and other therapeutic areas.
voyagertherapeutics.com LinkedIn Twitter
Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
FAQ
When is Voyager Therapeutics' presentation at Chardan’s Genetic Medicines Conference?
What is the date of the Truist Securities Genetic Medicine Summit?
Where can I access Voyager Therapeutics' conference presentations?
Will the CNS panel discussion at the Truist Securities Summit be webcast?